Ph.D. Daniel Billen - 18 May 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Daniel Billen, Ph.D.
Issuer symbol
AUPH
Transactions as of
18 May 2022
Net transactions value
$0
Form type
4
Filing time
20 May 2022, 16:09:30 UTC
Previous filing
16 Jun 2021
Next filing
23 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Unit Award $0 +8,733 $0.000000 8,733 18 May 2022 Common Shares 8,733 Direct F1
transaction AUPH Stock Option (right to buy) Award $0 +14,612 $0.000000 14,612 18 May 2022 Common Stock 14,612 $11.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.
F2 The option vests in twelve equal monthly installments commencing on June 18, 2022.